Clinical Trials Directory

Trials / Completed

CompletedNCT07110675

Central Sensitisation in Patients With Haemophilia and Degenerative Arthropathy

Identification of Central Sensitisation in Patients With Haemophilia and Degenerative Arthropathy of the Lower Limbs. A Cross-sectional Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
146 (actual)
Sponsor
Investigación en Hemofilia y Fisioterapia · Network
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Introduction: Hemophilic arthropathy is characterized by functional impairments, disabling physical sequelae, and chronic pain. Central pain sensitization describes increased neural excitability characterized by spontaneous or persistent pain, increased pain areas, allodynia, and hyperalgesia. Objectives: To evaluate central pain sensitization in patients with hemophilia and degenerative knee and ankle arthropathy and to identify the best predictive model of central pain sensitization in these patients. Methods: Multicenter cross-sectional cohort study. Eighty-six patients with hemophilic knee and ankle arthropathy will be recruited through the Spanish Hemophilia Federation. The primary outcome measure will be central pain sensitization (Central Sensitization Inventory), with age as the dependent variable. The secondary variables will be kinesiophobia (Tampa Scale for Kinesiophobia), catastrophizing (Pain Catastrophizing Scale), and pain anxiety (Pain Anxiety Symptoms Scale-20). The variables estimated as modifiers or confounders will be pain intensity (Visual Analogue Scale), joint status (Hemophilia Joint Health Score), severity and type of hemophilia, development of inhibitors, and sociodemographic variables. Expected results: To identify the degree of central pain sensitization in patients with hemophilic arthropathy. To identify the best predictive model for central pain sensitization in these patients based on the study variables.

Conditions

Timeline

Start date
2025-08-01
Primary completion
2025-10-28
Completion
2025-12-15
First posted
2025-08-07
Last updated
2026-02-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07110675. Inclusion in this directory is not an endorsement.